ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $11,000 | -8.3% | 4,000 | 0.0% | 0.00% | +33.3% |
| Q1 2022 | $12,000 | -25.0% | 4,000 | 0.0% | 0.00% | -40.0% |
| Q4 2021 | $16,000 | -5.9% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $17,000 | +41.7% | 4,000 | 0.0% | 0.01% | +25.0% |
| Q2 2021 | $12,000 | -7.7% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $13,000 | -7.1% | 4,000 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $14,000 | +7.7% | 4,000 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $13,000 | +85.7% | 4,000 | 0.0% | 0.01% | +66.7% |
| Q2 2020 | $7,000 | +75.0% | 4,000 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $4,000 | -63.6% | 4,000 | 0.0% | 0.00% | -60.0% |
| Q4 2019 | $11,000 | +83.3% | 4,000 | 0.0% | 0.01% | +66.7% |
| Q3 2019 | $6,000 | -45.5% | 4,000 | +33.3% | 0.00% | -50.0% |
| Q1 2019 | $11,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |